Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
07.02.24
/
50%
€289.60
Target price
07.02.25
€324.87
Performance (%)
-1.74%
End price
08.02.25
€284.55
Summary
This prediction ended on 08.02.25 with a price of €284.55. With a performance of -1.74%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. The_Goldman_Sachs_Gr has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.32 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.363% | -1.363% | 5.351% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten